Equine Infectious Anemia (EIA) – Coggins Test in Horses
Equine Infectious Anemia – Coggins Test in Horses
American Association of Equine Practitioners
By: Robert N. Olgesby, DVM
Contact usfor a no obligation quote or information about EIA and Coggins in Horses!
Equine Infectious Anemia (EIA) Introduction:
Equine Infectious Anemia is a viral disease of horses for which there is no cure, nor is there a vaccine to prevent this disease. Equine infectious anemia is a disease of horses characterized by three clinically distinct forms. That range from a rapidly worsening febrile disease that results in death to a unapparently ill chronic carrier form. First described over 150 years ago in Europe, the disease has been seen in the United States for more than 75 years. In 1970 an agar-gel immunodiffusion (AGID) test, the Coggins test, capable of detecting in-apparent virus carriers. This test, along with improved knowledge about EIAV transmission, has made effective control of the infection among horse populations a reality. This article discusses how horses get this disease, clinical signs, testing for EIA and its reliability, and the handling of infected horses.
Equine Infectious Anemia (EIA) is a disease that threatens the world’s horse, donkey and mule populations. Despite testing and measures to eradicate the equine infectious anemia virus (EIAV), more than 500 new cases are identified each year in the U.S. There is no cure for EIA. Although most infected horses show no symptoms, they remain contagious for life, endangering the health of other horses. For this reason, the United States Department of Agriculture (USDA,www.usda.gov) and state animal health regulatory agencies require euthanasia or strict lifelong quarantine for horses testing positive for EIAV.
Equine Infectious Anemia
understanding the importance of the Coggins Test
EQUINE INFECTIOUS ANEMIA – Explained
Equine infectious anemia is a potentially fatal viral disease. EIAV reproduces in white blood cells that circulate throughout the body. The immune system, via antibodies, may attack and destroy red blood cells, leading to anemia. Inflammation associated with the viral infection may damage vital organs, such as bone marrow, liver, heart and kidney. Secondary infections (e.g. pneumonia) may occur due to subsequent immunosupression. EIAV-infected horses may die from the direct effects of the virus or from secondary infections. EIA generally has three forms:
Acute
- Acute: Seen within one to two weeks after the horse’s first exposure to the virus, this phase is the most detrimental. It may be difficult to accurately diagnose acutely infected horses, as antibodies are not immediately produced and anemia is not present at this stage. However, the virus is active, multiplying and damaging the immune system and other organ systems.
Chronic
Inapparent
- Inapparent: Over time, the periodic episodes decrease in severity and frequency. Within a one-year period many horses begin to control the infection and show no clinical signs or problems. These unapparent carriers are infected for life and may be a source of infection for other horses. It is recommended that horse owners implement an EIA control plan for their premises.
SYMPTOMS
EIA may be difficult to diagnose because the symptoms are not specific and may vary from horse to horse. Additionally, individuals may demonstrate no obvious signs (inapparent carriers). Signs may include one or more of the following:
- Fever (temperature may even exceed 105 degrees F)
- Depression
- Mucosal petechial hemorrhages
- Decreased platelet numbers (thrombocytopenia)
- Decreased red blood cell numbers (anemia)
- Swelling of legs, lower chest and abdomen (edema)
- Decreased appetite (anorexia)
- Fatigue, reduced stamina or weakness
THE COGGINS (AGID) and C-ELISA TESTS
The only way to accurately determine whether a horse is infected with the EIA virus is by identifying antibodies in the blood via agar gel immunodiffusion (AGID) or competitive enzyme linked immunoadsorbent assay (C-ELISA) tests. The AGID method is considered the “gold standard” and is commonly known as the Coggins test. This test was developed 25 years ago by veterinary researcher Dr. Leroy Coggins. A negative Coggins test means there are no detectable antibodies at the time of testing. A positive test indicates the horse is infected and a carrier of the virus. C-ELISA tests offer the advantage of rapid results. However, false-positive results are more common with the C-ELISA tests and positive results should be verified by a standard Coggins (AGID) test. Foals may be false positive due to maternal antibodies passed via colostrum for as long as six months with either test.
THE ONLY PROTECTION IS PREVENTION
There is no effective treatment for EIA. There is no vaccine to prevent it. There is no cure. However, good management can reduce the potential of infection. The following guidelines will help:
- Use disposable needles and syringes (one per horse) when administering vaccines and medications.
- Sterilize dental tools and other instruments before using them on another horse.
- Test all horses for EIA at least annually.
- Test horses at the time of purchase examination.
- Stable owners, horse show and event managers should require and verify current negative Coggins certificates for all horses entering the premises.
- New horses should be quarantined for 45 days and observed for any signs of illness, including elevated temperatures, before introducing them to the herd. They should be retested if exposure to EIA is suspected at a 45-day interval.
- All stable areas should be kept clean, dry and waste-free. Good pasture management techniques should also be practiced. Remove manure and provide adequate drainage to discourage breeding sites for pests.
- Horses that are at greater risk (such as animals who are in frequent contact with outside horses or who live or travel in geographic regions known for EIA outbreaks) should be tested more frequently, ideally every four to six months.